Literature DB >> 36152197

Radiometric Assay of ABHD2 Activity.

Domenico Fazio1, Emanuele Criscuolo2,3, Mauro Maccarrone2,4.   

Abstract

The α,β-hydrolase fold-containing protein 2 (ABHD2) is a serine hydrolase, responsible for the cleavage of endogenous 2-arachidonoylglycerol (2-AG). ABHD2 is activated by progesterone, thus, it is considered a nonnuclear receptor of this steroid hormone that terminates its biological effects. The products of ABHD2-catalyzed cleavage by the natural substrate 2-AG are glycerol and arachidonic acid; here, instead of 2-AG, the radioactive substrate 2-oleoyl-[3H]glycerol has been used as already done in various acylglycerol lipase activity assays. The amount of [3H]glycerol released allows to measure ABHD2 enzymatic activity.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ABHD2; Acylglycerol lipase; Bioactive lipids; Endocannabinoids; Progesterone receptor; U2OS cells

Mesh:

Substances:

Year:  2023        PMID: 36152197     DOI: 10.1007/978-1-0716-2728-0_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Regulation of the sperm calcium channel CatSper by endogenous steroids and plant triterpenoids.

Authors:  Nadja Mannowetz; Melissa R Miller; Polina V Lishko
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

2.  Unconventional endocannabinoid signaling governs sperm activation via the sex hormone progesterone.

Authors:  Melissa R Miller; Nadja Mannowetz; Anthony T Iavarone; Rojin Safavi; Elena O Gracheva; James F Smith; Rose Z Hill; Diana M Bautista; Yuriy Kirichok; Polina V Lishko
Journal:  Science       Date:  2016-03-17       Impact factor: 47.728

3.  Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration.

Authors:  Daisuke Obinata; Shogo Takada; Ken-ichi Takayama; Tomohiko Urano; Akiko Ito; Daisaku Ashikari; Kyoko Fujiwara; Yuta Yamada; Taro Murata; Jinpei Kumagai; Tetsuya Fujimura; Kazuhiro Ikeda; Kuniko Horie-Inoue; Yukio Homma; Satoru Takahashi; Satoshi Inoue
Journal:  Eur J Cancer       Date:  2016-02-06       Impact factor: 9.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.